Describe The Mechanism of Action of Ixekizumab

In this medication review video module, join Christy Vath, a Physician Assistant at Seattle Rheumatology. Christy provides an overview of the mechanism of action of ixekizumab. This humanized monoclonal antibody targets and neutralizes IL-17A, a pro-inflammatory cytokine involved in autoimmune diseases like psoriasis, psoriatic arthritis, and axial spondylarthritis. By inhibiting IL-17A, ixekizumab helps to modulate the inflammatory response, reducing tissue damage and improving symptoms.